ArticleInternational journal of molecular sciences2020

Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma.

Thi Bich Uyen Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.